Clinical Trial Update: Trial of Oral Community SVMP INhibitors for Snakebite [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating oral SVMP inhibitors for snakebite envenomation. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Snakebite Envenomation

Snippet

Sponsor: Liverpool School of Tropical Medicine | Conditions: Snakebite | Phase 2 | Status: NOT_YET_RECRUITING